Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
1.620
-0.030 (-1.82%)
At close: Mar 13, 2025, 4:00 PM
1.550
-0.070 (-4.32%)
After-hours: Mar 13, 2025, 7:08 PM EST
Eyenovia Revenue
Eyenovia had revenue of $1.63K in the quarter ending September 30, 2024, with 35.64% growth. This brings the company's revenue in the last twelve months to $31.83K, up 2,557.10% year-over-year. In the year 2023, Eyenovia had annual revenue of $3.79K.
Revenue (ttm)
$31.83K
Revenue Growth
+2,557.10%
P/S Ratio
34.80
Revenue / Employee
$558
Employees
57
Market Cap
3.39M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
EYEN News
- 15 days ago - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewsWire
- 17 days ago - Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - GlobeNewsWire
- 5 weeks ago - Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewsWire
- 6 weeks ago - Eyenovia Announces 1-for-80 Reverse Stock Split - GlobeNewsWire
- 2 months ago - Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - GlobeNewsWire
- 2 months ago - Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewsWire
- 3 months ago - Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - GlobeNewsWire
- 3 months ago - Eyenovia Provides Update on Restructuring Efforts - GlobeNewsWire